← Back to directory

Carolyn S.P. Lam

Researcher Next ID · RN-023899

Researcher · Medicine

Harvard University

Cambridge, Singapore

Not currently recruitingFunding unknown
Works count
1,004
Citation count
107,337
H-index
133
i10-index
596

Research interests

Medicine
Heart Failure Treatment and Management
Cardiovascular Function and Risk Factors
Diabetes Treatment and Management
Cardiac pacing and defibrillation studies
Cardiac Fibrosis and Remodeling

Publications

  • Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction

    New England Journal of Medicine · 2024 · https://doi.org/10.1056/nejmoa2407107

  • 2023 Focused Update of the 2021 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure

    European Journal of Heart Failure · 2024 · 10.1002/ejhf.3024

  • 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

    European Heart Journal · 2023 · https://doi.org/10.1093/eurheartj/ehad195

  • The global burden of metabolic disease: Data from 2000 to 2019

    Cell Metabolism · 2023 · https://doi.org/10.1016/j.cmet.2023.02.003

  • 2021 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure

    European Journal of Heart Failure · 2022 · https://doi.org/10.1002/ejhf.2333

  • Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction

    New England Journal of Medicine · 2022 · 10.1056/nejmoa2206286

  • SGLT2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials

    The Lancet · 2022 · https://doi.org/10.1016/s0140-6736(22)01429-5

  • Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes

    New England Journal of Medicine · 2021 · 10.1056/nejmoa2108269

  • Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure

    European Journal of Heart Failure · 2021 · 10.1002/ejhf.2115

  • Empagliflozin in Heart Failure with a Preserved Ejection Fraction

    New England Journal of Medicine · 2021 · 10.1056/nejmoa2107038

  • Corrigendum to: 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC

    European Heart Journal · 2021 · 10.1093/eurheartj/ehab670

  • 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

    European Heart Journal · 2021 · 10.1093/eurheartj/ehab368

  • Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials

    The Lancet Diabetes & Endocrinology · 2021 · 10.1016/s2213-8587(21)00203-5

  • The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030

    The Lancet · 2021 · 10.1016/s0140-6736(21)00684-x

  • Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction

    New England Journal of Medicine · 2020 · 10.1056/nejmoa1915928

  • How to diagnose heart failure with preserved ejection fraction: the HFA–PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)

    European Heart Journal · 2019 · 10.1093/eurheartj/ehz641

  • Sex differences in heart failure

    European Heart Journal · 2019 · 10.1093/eurheartj/ehz835

  • Prevalence and correlates of coronary microvascular dysfunction in heart failure with preserved ejection fraction: PROMIS-HFpEF

    European Heart Journal · 2018 · 10.1093/eurheartj/ehy531

  • Sex Differences in Cardiovascular Pathophysiology

    Circulation · 2018 · 10.1161/circulationaha.118.034271

  • Noncardiac Comorbidities in Heart Failure With Reduced Versus Preserved Ejection Fraction

    Journal of the American College of Cardiology · 2014 · 10.1016/j.jacc.2014.08.036

  • The Global Health and Economic Burden of Hospitalizations for Heart Failure

    Journal of the American College of Cardiology · 2014 · 10.1016/j.jacc.2013.11.053

  • Exercise Hemodynamics Enhance Diagnosis of Early Heart Failure With Preserved Ejection Fraction

    Circulation Heart Failure · 2010 · 10.1161/circheartfailure.109.930701

  • Global Cardiovascular Reserve Dysfunction in Heart Failure With Preserved Ejection Fraction

    Journal of the American College of Cardiology · 2010 · 10.1016/j.jacc.2010.03.077

  • Epidemiology and Clinical Course of Heart Failure with Preserved Ejection Fraction

    European Journal of Heart Failure · 2010 · 10.1093/eurjhf/hfq121

  • Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction

    Journal of the American College of Cardiology · 2009 · 10.1016/j.jacc.2008.11.051

  • Cardiac Structure and Ventricular–Vascular Function in Persons With Heart Failure and Preserved Ejection Fraction From Olmsted County, Minnesota

    Circulation · 2007 · 10.1161/circulationaha.106.659763

Current projects

    No projects listed.